Pranshu Sahgal, Ph.D.

Cell and Molecular biologist in cancer biology

Research Expertise

Cancer Biology
Cancer Signaling
Cancer Genomics
Drug Discovery and Development
Cell Biology
Developmental Biology
Molecular Biology
Genetics
Biochemistry
Structural Biology
Hepatology
Gastroenterology
Microbiology
Virology
Infectious Diseases
Parasitology
Cancer Research
Oncology

About

·         Cell and Molecular Biologist with a robust background in translational research, specializing in identifying novel molecular biomarkers, drug targets, and mechanism of action for advancing early cancer diagnosis and targeted cancer treatment. ·         Recognized for a proven track record of scientific innovation, evidenced by: ○        15+ scientific papers (6 as first/co-first author) having direct clinical development implications; 800+ citations. ○        20+ new collaborations; Presentations of scientific data in 10+ national/international conferences. ○        $350,000 as personal grant award acquisition from 10 foundations. ·         Exemplary collaborator and communicator with deep expertise in latest culture models, molecular biology techniques, assay development and Good Laboratory Practice (GLP). Demonstrated ability to effectively manage multiple projects, exhibiting exceptional organizational skills and keen attention to detail, leveraging innovative thinking to drive research forward. ·         Certified Medical Affairs Specialist with an understanding of clinical study and trials, contributing to regulatory submissions and fostering relationships with Key Opinion Leaders (KOLs), Contract Research Organizations (CROs), and other key stakeholders.

Publications

Integrin traffic – the update

Journal of Cell Science / Jan 01, 2015

De Franceschi, N., Hamidi, H., Alanko, J., Sahgal, P., & Ivaska, J. (2015). Integrin traffic – the update. Journal of Cell Science. https://doi.org/10.1242/jcs.161653

AMPK negatively regulates tensin-dependent integrin activity

Journal of Cell Biology / Mar 13, 2017

Georgiadou, M., Lilja, J., Jacquemet, G., Guzmán, C., Rafaeva, M., Alibert, C., Yan, Y., Sahgal, P., Lerche, M., Manneville, J.-B., Mäkelä, T. P., & Ivaska, J. (2017). AMPK negatively regulates tensin-dependent integrin activity. Journal of Cell Biology, 216(4), 1107–1121. https://doi.org/10.1083/jcb.201609066

Tensin-4-Dependent MET Stabilization Is Essential for Survival and Proliferation in Carcinoma Cells

Developmental Cell / May 01, 2014

Muharram, G., Sahgal, P., Korpela, T., De Franceschi, N., Kaukonen, R., Clark, K., Tulasne, D., Carpén, O., & Ivaska, J. (2014). Tensin-4-Dependent MET Stabilization Is Essential for Survival and Proliferation in Carcinoma Cells. Developmental Cell, 29(4), 421–436. https://doi.org/10.1016/j.devcel.2014.03.024

SORLA regulates endosomal trafficking and oncogenic fitness of HER2

Nature Communications / May 28, 2019

Pietilä, M., Sahgal, P., Peuhu, E., Jäntti, N. Z., Paatero, I., Närvä, E., Al-Akhrass, H., Lilja, J., Georgiadou, M., Andersen, O. M., Padzik, A., Sihto, H., Joensuu, H., Blomqvist, M., Saarinen, I., Boström, P. J., Taimen, P., & Ivaska, J. (2019). SORLA regulates endosomal trafficking and oncogenic fitness of HER2. Nature Communications, 10(1). https://doi.org/10.1038/s41467-019-10275-0

Regulation of Cell Migration and β1 Integrin Trafficking by the Endosomal Adaptor GGA3

Traffic / Apr 05, 2016

Ratcliffe, C. D. H., Sahgal, P., Parachoniak, C. A., Ivaska, J., & Park, M. (2016). Regulation of Cell Migration and β1 Integrin Trafficking by the Endosomal Adaptor <scp>GGA3</scp>. Traffic, 17(6), 670–688. Portico. https://doi.org/10.1111/tra.12390

GGA2 and RAB13 promote activity-dependent β1-integrin recycling

Jun 22, 2018

Sahgal, P., Alanko, J., Icha, J., Paatero, I., Hamidi, H., Arjonen, A., Pietilä, M., Rokka, A., & Ivaska, J. (2018). GGA2 and RAB13 promote activity-dependent β1-integrin recycling. https://doi.org/10.1101/353086

An Enhancer-Driven Stem Cell–Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer

Gastroenterology / Jan 01, 2022

Liang, X., Duronio, G. N., Yang, Y., Bala, P., Hebbar, P., Spisak, S., Sahgal, P., Singh, H., Zhang, Y., Xie, Y., Cejas, P., Long, H. W., Bass, A. J., & Sethi, N. S. (2022). An Enhancer-Driven Stem Cell–Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer. Gastroenterology, 162(1), 209–222. https://doi.org/10.1053/j.gastro.2021.09.044

Loss of ADAM9 expression impairs β1 integrin endocytosis, focal adhesion formation and cancer cell migration

Journal of Cell Science / Jan 01, 2017

Mygind, K. J., Schwarz, J., Sahgal, P., Ivaska, J., & Kveiborg, M. (2017). Loss of ADAM9 expression impairs β1 integrin endocytosis, focal adhesion formation and cancer cell migration. Journal of Cell Science. https://doi.org/10.1242/jcs.205393

Structural and antigenic variance between novel influenza A/H1N1/2009 and influenza A/H1N1/2008 viruses

The Journal of Infection in Developing Countries / Nov 26, 2009

Saxena, S. K., Mishra, N., Saxena, R., Swamy, M. A., Sahgal, P., Saxena, S., Tiwari, S., Mathur, A., & Nair, M. P. (2009). Structural and antigenic variance between novel influenza A/H1N1/2009 and influenza A/H1N1/2008 viruses. The Journal of Infection in Developing Countries, 4(01), 001–006. https://doi.org/10.3855/jidc.546

Early TP53 Alterations Shape Gastric and Esophageal Cancer Development

Cancers / Nov 24, 2021

Sahgal, P., Huffman, B. M., Patil, D. T., Chatila, W. K., Yaeger, R., Cleary, J. M., & Sethi, N. S. (2021). Early TP53 Alterations Shape Gastric and Esophageal Cancer Development. Cancers, 13(23), 5915. https://doi.org/10.3390/cancers13235915

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma

Scientific Reports / Nov 23, 2023

Prosz, A., Duan, H., Tisza, V., Sahgal, P., Topka, S., Klus, G. T., Börcsök, J., Sztupinszki, Z., Hanlon, T., Diossy, M., Vizkeleti, L., Stormoen, D. R., Csabai, I., Pappot, H., Vijai, J., Offit, K., Ried, T., Sethi, N., Mouw, K. W., … Szallasi, Z. (2023). Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-47946-4

Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer

Clinical Cancer Research / Oct 24, 2022

Peng, K., Zhang, F., Wang, Y., Sahgal, P., Li, T., Zhou, J., Liang, X., Zhang, Y., Sethi, N., Liu, T., Zhang, H., & Bass, A. J. (2022). Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer. Clinical Cancer Research, 29(1), 197–208. https://doi.org/10.1158/1078-0432.ccr-22-1609

Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors

iScience / Nov 01, 2023

Sahgal, P., Patil, D. T., Bala, P., Sztupinszki, Z. M., Tisza, V., Spisak, S., Luong, A. G., Huffman, B., Prosz, A., Singh, H., Lazaro, J.-B., Szallasi, Z., Cleary, J. M., & Sethi, N. S. (2023). Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors. IScience, 26(11), 108169. https://doi.org/10.1016/j.isci.2023.108169

Replicative stress in gastroesophageal adenocarcinoma is associated with chromosomal instability and sensitivity to DNA damage response inhibitors

Mar 28, 2023

Sahgal, P., Patil, D. T., Sztupinszki, Z. M., Tisza, V., Spisak, S., Huffman, B., Prosz, A., Singh, H., Lazaro, J.-B., Szallasi, Z., Cleary, J. M., & Sethi, N. S. (2023). Replicative stress in gastroesophageal adenocarcinoma is associated with chromosomal instability and sensitivity to DNA damage response inhibitors. https://doi.org/10.1101/2023.03.27.534412

Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting

npj Precision Oncology / Apr 08, 2024

Prosz, A., Sahgal, P., Huffman, B. M., Sztupinszki, Z., Morris, C. X., Chen, D., Börcsök, J., Diossy, M., Tisza, V., Spisak, S., Likasitwatanakul, P., Rusz, O., Csabai, I., Cecchini, M., Baca, Y., Elliot, A., Enzinger, P., Singh, H., Ubellaker, J., … Sethi, N. S. (2024). Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting. Npj Precision Oncology, 8(1). https://doi.org/10.1038/s41698-024-00561-6

Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiency

Apr 01, 2024

Szallasi, Z., Diossy, M., Tisza, V., Li, H., Sahgal, P., Zhou, J., Sztupinszki, Z., Young, D., Nuosome, D., Kuo, C., Jiang, J., Chen, Y., Ebner, R., Sesterhenn, I., Moncur, J., Chesnut, G., Petrovics, G., T.Klus, G., Valcz, G., … Spisak, S. (2024). Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiency. https://doi.org/10.21203/rs.3.rs-3995251/v1

RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

Clinical Cancer Research / Mar 05, 2024

Singh, H., Sahgal, P., Kapner, K., Corsello, S. M., Gupta, H., Gujrathi, R., Li, Y. Y., Cherniack, A. D., El Alam, R., Kerfoot, J., Andrews, E., Lee, A., Nambiar, C., Hannigan, A. M., Remland, J., Brais, L., Leahy, M. E., Rubinson, D. A., Schlechter, B. L., … Cleary, J. M. (2024). RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clinical Cancer Research, OF1–OF16. https://doi.org/10.1158/1078-0432.ccr-23-2581

20P Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting

ESMO Open / Mar 01, 2023

Sahgal, P. (2023). 20P Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting. ESMO Open, 8(1), 100986. https://doi.org/10.1016/j.esmoop.2023.100986

Diagnostic tool to identify and treat DNA repair deficient gastroesophageal adenocarcinomas

Jul 16, 2022

Prosz, A., Sahgal, P., Morris, C. X., Sztupinszki, Z., Börcsök, J., Diossy, M., Tisza, V., Spisak, S., Rusz, O., Csabai, I., Huffman, B. M., Singh, H., Lazaro, J.-B., Cecchini, M., Cleary, J. M., Szallasi, Z., & Sethi, N. S. (2022). Diagnostic tool to identify and treat DNA repair deficient gastroesophageal adenocarcinomas. https://doi.org/10.1101/2022.07.14.500118

SORLA-driven endosomal trafficking regulates the oncogenic fitness of HER2

Apr 11, 2018

Pietilä, M., Sahgal, P., Peuhu, E., Jäntti, N., Paatero, I., Andersen, O. M., Padzik, A., Blomqvist, M., Saarinen, I., Boström, P., Taimen, P., & Ivaska, J. (2018). SORLA-driven endosomal trafficking regulates the oncogenic fitness of HER2. https://doi.org/10.1101/299586

Education

University of Turku

Ph.D., Cell and molecular biology / November, 2018

Turku

Experience

Dana-Farber Cancer Institute and Harvard Medical School

Links & Social Media

Join Pranshu on NotedSource!
Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.

Expert Institutions
NotedSource has experts from Stanford University
Expert institutions using NotedSource include Oxfort University
Experts from McGill have used NotedSource to share their expertise
University of Chicago experts have used NotedSource
MIT researchers have used NotedSource
Proudly trusted by
Microsoft uses NotedSource for academic partnerships
Johnson & Johnson academic research projects on NotedSource
ProQuest (Clarivate) uses NotedSource as their industry academia platform
Slamom consulting engages academics for research collaboration on NotedSource
Omnicom and OMG find academics on notedsource
Unilever research project have used NotedSource to engage academic experts